• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Practical ways to deal with the high burden of cardiovascular disease in hemodialysis patients.应对血液透析患者心血管疾病高负担的实用方法。
Sao Paulo Med J. 2006 Jan 5;124(1):36-41. doi: 10.1590/s1516-31802006000100008. Epub 2006 Apr 3.
2
Cardiac and cerebrovascular disease in chronic uremia.
Am J Kidney Dis. 1993 Jan;21(1):77-80. doi: 10.1016/s0272-6386(12)80726-8.
3
Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.强化血液透析、左心室肥厚与心血管疾病。
Am J Kidney Dis. 2016 Nov;68(5S1):S5-S14. doi: 10.1053/j.ajkd.2016.05.025.
4
Options in dialysis therapy: significance of cardiovascular findings.透析治疗的选择:心血管检查结果的意义
Kidney Int Suppl. 1993 Feb;40:S85-91.
5
Left ventricular hypertrophy is a risk factor independent of hypertension in survival of hemodialyzed patients.
Ren Fail. 2002 Mar;24(2):175-86. doi: 10.1081/jdi-120004094.
6
Cardiovascular problems in dialysis patients: impact on survival.透析患者的心血管问题:对生存的影响。
Adv Perit Dial. 2010;26:47-52.
7
[Risk factors and cardiovascular disease in uremic patients].
Nefrologia. 2002;22 Suppl 4:1-6.
8
Polymorphism related to cardiovascular risk in hemodialysis subjects: a systematic review.血液透析患者中与心血管风险相关的多态性:一项系统综述。
J Bras Nefrol. 2018 Apr-Jun;40(2):179-192. doi: 10.1590/2175-8239-jbn-3857. Epub 2018 Jun 18.
9
Experience in treatment of "non ideal" patients with chronic renal insufficiency.
J Fla Med Assoc. 1967 Dec;54(12):1144-6.
10
Cardiovascular disease in patients with end-stage renal disease on hemodialysis in a developing country.发展中国家接受血液透析的终末期肾病患者的心血管疾病
Saudi J Kidney Dis Transpl. 2012 Mar;23(2):262-6.

本文引用的文献

1
[Cardiovascular disease and risk factors in candidates for renal transplantation].
Arq Bras Cardiol. 2005 Feb;84(2):156-60. doi: 10.1590/s0066-782x2005000200012. Epub 2005 Mar 8.
2
Cardiovascular risk in dialysis patients: a comparison of risk factors and cardioprotective therapy between 1996 and 2001.透析患者的心血管风险:1996年至2001年间风险因素与心脏保护治疗的比较
Nephrology (Carlton). 2003 Aug;8(4):177-83. doi: 10.1046/j.1440-1797.2003.00157.x.
3
The challenge of cardiovascular risk factors in end-stage renal disease.终末期肾病中心血管危险因素的挑战
J Nephrol. 2003 Jul-Aug;16(4):476-86.
4
Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.肾脏疾病作为心血管疾病发生的危险因素:美国心脏协会心血管疾病肾脏、高血压研究、临床心脏病学以及流行病学与预防委员会的声明
Circulation. 2003 Oct 28;108(17):2154-69. doi: 10.1161/01.CIR.0000095676.90936.80.
5
Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States.美国慢性血液透析患者高血压的患病率、治疗与控制情况
Am J Med. 2003 Sep;115(4):291-7. doi: 10.1016/s0002-9343(03)00366-8.
6
Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing.与非侵入性检测相比,冠状动脉造影是肾移植候选者发生事件的最佳预测指标。
Hypertension. 2003 Sep;42(3):263-8. doi: 10.1161/01.HYP.0000087889.60760.87. Epub 2003 Aug 11.
7
Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction.终末期肾病合并急性心肌梗死患者的阿司匹林、β受体阻滞剂及血管紧张素转换酶抑制剂治疗
J Am Coll Cardiol. 2003 Jul 16;42(2):201-8. doi: 10.1016/s0735-1097(03)00572-2.
8
Nephrology in Latin America, with special emphasis on Brazil.拉丁美洲的肾脏病学,特别关注巴西。
Kidney Int Suppl. 2003 Feb(83):S131-4. doi: 10.1046/j.1523-1755.63.s83.28.x.
9
Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure.
Semin Dial. 2003 Mar-Apr;16(2):111-7. doi: 10.1046/j.1525-139x.2003.160271.x.
10
Effect of dialysis dose and membrane flux in maintenance hemodialysis.透析剂量和膜通量在维持性血液透析中的作用
N Engl J Med. 2002 Dec 19;347(25):2010-9. doi: 10.1056/NEJMoa021583.

应对血液透析患者心血管疾病高负担的实用方法。

Practical ways to deal with the high burden of cardiovascular disease in hemodialysis patients.

作者信息

Lima José Jayme Galvão de

机构信息

Instituto do Coração, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.

出版信息

Sao Paulo Med J. 2006 Jan 5;124(1):36-41. doi: 10.1590/s1516-31802006000100008. Epub 2006 Apr 3.

DOI:10.1590/s1516-31802006000100008
PMID:16612461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11060401/
Abstract

Cardiovascular disease is the main cause of death among hemodialysis patients. Although uremia by itself may be considered to be a cardiovascular risk factor, a significant proportion of dialysis patients die because of cardiovascular disease not directly attributable to uremia. Indeed, many of the cardiovascular diseases and cardiovascular risk factors in these patients are common to those occurring in the general population and are amenable to intervention. Lack of proper medical care during the early stages of renal insufficiency and present-day dialysis routines, by failing to correct hypertension, hypervolemia and left ventricular hypertrophy in many patients, may also add to the cardiovascular burden. The author suggests that, in addition to early treatment and referral to a specialist, chronic renal failure patients should undergo intensive cardiovascular screening and treatment, and correction of cardiovascular risk factors based on guidelines established for the general population.

摘要

心血管疾病是血液透析患者的主要死因。虽然尿毒症本身可被视为一种心血管危险因素,但相当一部分透析患者死于并非直接由尿毒症导致的心血管疾病。实际上,这些患者中的许多心血管疾病和心血管危险因素与普通人群中出现的情况相同,并且可以进行干预。在肾功能不全早期缺乏适当的医疗护理以及当前的透析程序,由于未能纠正许多患者的高血压、血容量过多和左心室肥厚,也可能加重心血管负担。作者建议,除了早期治疗和转诊至专科医生外,慢性肾衰竭患者应接受强化的心血管筛查和治疗,并根据针对普通人群制定的指南纠正心血管危险因素。